The TNBC subtype is chracterized by lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), representing 5-10% of all breast cancers [3]. This evidence concerns the gene PGR and breast carcinoma.